91 related articles for article (PubMed ID: 6522380)
1. [Pulmonary hypertension in diffuse fibrosing alveolitis].
Shatalov NN; Guseĭnov SN
Probl Tuberk; 1984 Dec; (12):29-33. PubMed ID: 6522380
[No Abstract] [Full Text] [Related]
2. [The significance of hypoxemia in the detection of pulmonary hypertension in cryptogenic fibrosing alveolitis].
Fucík J; Michaljanic A; Jezková L; Krása H; Drechslerová J; Jezek V
Cas Lek Cesk; 1983 Sep; 122(35):1079-81. PubMed ID: 6627323
[No Abstract] [Full Text] [Related]
3. Long-term development of pulmonary hypertension in cryptogenic fibrosing alveolitis.
Fucík J; Michaljanic A; Jezková L; Jezek V
Cor Vasa; 1980; 22(4):245-50. PubMed ID: 7449393
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in a patient with diffuse fibrosing alveolitis due to rheumatoid arthritis.
Skwarski K; Zieliński J
Cor Vasa; 1986; 28(3):206-9. PubMed ID: 3743089
[TBL] [Abstract][Full Text] [Related]
5. [Diffuse fibrosing alveolitis and primary biliary cirrhosis].
Smith J; Sørensen PG; Pallisgaard G
Ugeskr Laeger; 1990 Jun; 152(25):1832-3. PubMed ID: 2363221
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary hypertension in a patient with pulmonary fibrosis and rheumatoid arthritis].
Skwarski K
Pneumonol Pol; 1985 Mar; 53(3):151-5. PubMed ID: 4022794
[No Abstract] [Full Text] [Related]
7. The prognosis and development of pulmonary hypertension in idiopathic diffuse interstitial lung fibrosis.
Jezek V
G Ital Cardiol; 1984; 14 Suppl 1():39-45. PubMed ID: 6534765
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis of pulmonary hypertension in cryptogenic fibrosing alveolitis of the lung].
Jezek V; Fucík J
Vnitr Lek; 1979 Jul; 25(7):635-40. PubMed ID: 494497
[No Abstract] [Full Text] [Related]
9. [Outcome of idiopathic fibrosing alveolitis and its relation to indicators of pulmonary hemodynamics and respiration].
Egurnov NI; Aleksandrov AL; Semenova LA; Veselova EV
Probl Tuberk; 1987; (7):10-2. PubMed ID: 3658957
[No Abstract] [Full Text] [Related]
10. The prognostic significance of functional tests in cryptogenic fibrosing alveolitis.
Jezek V; Fucik J; Michaljanic A; Jezkova L
Bull Eur Physiopathol Respir; 1980; 16(6):711-20. PubMed ID: 7448462
[TBL] [Abstract][Full Text] [Related]
11. [Interstitial pulmonary fibrosis in the pathogenesis of pulmonary heart disease].
Stanĕk V; Widimský J; Kasalický J
Vnitr Lek; 1969 Jun; 15(6):546-56. PubMed ID: 5790732
[No Abstract] [Full Text] [Related]
12. [ECG and its significance for pulmonary hypertension diagnosis and for the estimation of prognosis in cryptogenic fibrosing pulmonary alveolitis (author's transl)].
Jezková L; Fucík J; Michaljanic A; Krása H; Jezek V
Cas Lek Cesk; 1981 Sep; 120(35):1050-4. PubMed ID: 7273071
[No Abstract] [Full Text] [Related]
13. [Vasaprostan treatment of fibrosing alveolitis in patients with pulmonary hypertension].
Popova EN; Bolevich SB; Litvitskiĭ PF; Arkhipova DV; Osipenko VI; Kogan EA; Kornev BM; Mukhin NA
Ter Arkh; 2004; 76(8):56-61. PubMed ID: 15471399
[TBL] [Abstract][Full Text] [Related]
14. Brain natriuretic peptide: is it helpful in detecting pulmonary hypertension in fibrotic lung disease?
Hill NS
Am J Respir Crit Care Med; 2004 Aug; 170(4):352-3. PubMed ID: 15302622
[No Abstract] [Full Text] [Related]
15. [Pulmonary hypertension in interstitial diseases of the lungs].
Arkhipova DV; Kornev BM; Popova EN; Osipenko VI; Fokina OA; Privalova EV; Kogan EA; Mukhin NA
Klin Med (Mosk); 2002; 80(6):28-33. PubMed ID: 12138797
[TBL] [Abstract][Full Text] [Related]
16. [Markers of thrombophilia in pulmonary fibrosis complicated by pulmonary hypertension].
Arkhipova DV; Privalova EV; Kozlovskaia LV; Kornev BM; Popova EN; Kraeva VV; Osipenko VI; Bitsadze VO
Ter Arkh; 2004; 76(3):43-9. PubMed ID: 15108458
[TBL] [Abstract][Full Text] [Related]
17. [Organic diseases and circulation: alveolar pneumonitis to pulmonary fibrosis--development of idiopathic pulmonary hypertension].
Fujimoto T
Nihon Rinsho; 1981 Oct; 39(10):3330-5. PubMed ID: 7339021
[No Abstract] [Full Text] [Related]
18. [Comparison between diffuse interstitial pneumonia of unknown etiology and primary pulmonary hypertension--concept of pulmonary connective tissue disease (PCTD)].
Kondo A; Kumano H
Kokyu To Junkan; 1979 Jan; 27(1):27-34. PubMed ID: 482742
[No Abstract] [Full Text] [Related]
19. [Pulmonary hypertension and fibrosis].
Cottin V
Rev Prat; 2014 Sep; 64(7):929. PubMed ID: 25362771
[No Abstract] [Full Text] [Related]
20. Pulmonary haemodynamics at rest and on exercise in patients with idiopathic pulmonary fibrosis.
Hawrylkiewicz I; Izdebska-Makosa Z; Grebska E; Zielinski J
Bull Eur Physiopathol Respir; 1982; 18(3):403-10. PubMed ID: 7074236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
